Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neurodegeneration and Neuroprotection in Multiple Sclerosis.
Multiple sclerosis and pregnancy: maternal considerations.
Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway.
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.
Structure and signalling in the IL-17 receptor family.
Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism.
Increasing age at disability milestones among MS patients in the MSBase Registry.
Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?
[Symptoms of circadian desynchronization in patients with multiple sclerosis.]
Multiple sclerosis: The potassium channel KIR4.1-a potential autoantigen in MS.
Genetic characterization of gliomas arising in patients with multiple sclerosis.
Type 1 immune response in progressive multiple sclerosis.
Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions.
Biologically plausible and evidence-based risk intervals in immunization safety research.
A combination trial of estriol plus glatiramer acetate in relapsing-remitting multiple sclerosis: effect on disabilities
Integrin/Chemokine Receptor Interactions in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with multiple sclerosis.
XIMINO (minocycline hydrochloride) capsule, extended release [Ranbaxy Laboratories Inc.]
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and upregulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
[Optic neuropathy and meningioma: A diagnostic trap.]
Effects of Topiramate on Dysaesthetic Pain in a Patient with Multiple Sclerosis.
A cluster randomised controlled trial on the efficacy of client-centred occupational therapy in multiple sclerosis: good process, poor outcome.
Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.
Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen.
A manual of diseases of the nervous system
Pages
« first
‹ previous
…
214
215
216
217
218
219
220
221
222
…
next ›
last »